We have studied a new approach for the resolution and absolute configuration
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Introduction
In the past years, we developed a route to synthesize and determine the absolute configuration of the different enantiomers of the squalene oxides using 2,3-and erythro-6,7-and 10,11-squalene diols (Sdiols) as intermediates. In this case, the resolution of the corresponding Sdiols was achieved by derivatization with MTPA (Mosher´s acid, Dmethoxy-D-trifluoromethylphenylacetic acid). In addition, we demonstrated that these enantiomers of the internal SOs were valuable substrates for inhibitory studies of Squalene Epoxidase (SE) leading to the epoxidation at both terminal double bonds of the squalene chain but affording regioselective and asymmetric ratios of enantiomers of squalene dioxides. 1 Likewise, we studied the activity and interactions of the resulting squalene dioxides with oxidosqualene-lanosterol cyclase (OSLC), another key enzyme in the cholesterol biosynthesis. 1 In this paper we report a practical new approach to resolve both enantiomers of the different squalene diols with high enantiomeric excesses by simple flash chromatography using as derivatizing agents chiral aryl acetic acids currently applied to determine the absolute configuration of secondary alcohols. For this purpose, the (S)-(+)-MPA, (S)-(+)-APA, and (S)-(+)-9-AMA diastereomeric esters from the above squalene diols were prepared ( Fig. 1 ) and separated by flash chromatography with silica gel. In addition, we present here the 1 H NMR data needed for the easy assignment of the absolute configuration of the derivatized secondary carbinols present in 2,3-and erythro-squalene diols and we compare these results with the more cumbersome assignation from data previously obtained for the above squalene diols derivatized with MTPA. 
Results and Discussion
Preparation, derivatization and separation of the 2,3-and erythro-squalene diols.
So far, there have been a great number of studies for the synthesis of chiral squalene epoxides. In most of these syntheses, 2,3-squalene diols were used as versatile key intermediates in the preparation of enantiomerally pure 2,3-squalene oxides. Other approaches were reported by using chiral synthons, 2 by enantioselective reactions 3 or by chemical resolution of the diols. 1, 4 among others. Previously, we had performed the chemical resolution strategy involving the formation of the (R)-MTPA esters of the corresponding enantiomers of 2,3-, erythro-6,7-and erythro-10,11-squalene diols. The obtained esters were submitted to HPLC chromatographic resolution and used for further determination of the absolute configuration of the stereogenic centers present at the squalene skeleton for each diastereoisomer. But HPLC chromatographic resolution by reverse phase HPLC was very tedious and difficult.
Our ongoing interest in resolving secondary alcohols with lipases 5 has led us to undertake the search for a new enzymatic strategy. In this context, specific lipases could be able to remove selectively the arylacetic group from the derivatized diasteromeric (S)-(+)-esters of the corresponding squalene diols. As a result, we would be able to separate both enantiomers of the racemic mixture facilitating the stereochemical studies of the resolved diol intermediate and determining the absolute configuration of both diasteromeric esters. Consequently, we decided to prove this strategy for arylacetic derivatized compounds which could be potential substrates with acylases or lipases and had been utilized in determining the absolute configuration of secondary alcohols, such as (S)-(+)-MPA, (S)-(+)-APA, and (S)-(+)-9-AMA esters. In this context, some representative model secondary alcohols were derivatized and enzymatically hydrolized but results were not so good as anticipated and this approach was disregarded. or (2) by using a carbodiimide in presence of DMAP. 5 Apparently, no important racemizations have been reported under the derivatization conditions described for these two methods and yields used to be higher than 90%.
Surprisingly, when we analyzed the reaction mixture by TLC we observed high differences of Rf in the TLC plate for all the squalene arylacetic esters prepared. As an example, TLC separation of diasteromeric esters was better for the derivatizing acid in the order 9-AMA> APAK MPA and for the derivatized diol in the order 10,11-> 6,7-> 2,3-squalene diol. As we expected, stability of products followed the order MPA >> APA > 9-AMA, since after 1 year of storage only 4% of MPA derivatized product was isomerized. 
Reduction or saponification of individual isomers of Sdiols esters with LiAlH 4 /Diethyl
Ether or K 2 CO 3 in MeOH, respectively, gave rise to the enantiomeric diols. As expected, sign of the optical rotation of the released squalene diol confirmed the absolute configuration assignment. Since resolution has been so good, we expected that the optical purity of the enantiomerically pure squalene diols were in agreement with the enantiomeric purity of the ester precursors. However, rederivatization with (S)-(+)-MPA of each one of the resulting squalene diols and TLC and HPLC analysis of the resulting esters showed that there was 6-8% of isomerized alcohol. This isomerization was much more important (up to 12%) for squalene diols previously derivatized with (S)-(+)-APA and by the acyl chloride method. These results are somewhat worse than those observed for the derivatized squalene diols obtained after rederivatization with
MTPA that showed 5% of isomerization. In spite of the higher degree of isomerization, any of the recovered enantiomerically enriched squalene diols could be useful as squalene oxides intermediates to perform any biological experiment.
In conclusion, we have improved the methodology for the separation and absolute configuration determination of the different squalenediol stereoisomers that afford the solution, concentrated at reduced pressure and purified by flash chromatography on silica gel using a gradient of 0-30% MTBE in hexane (85-92% yield). 
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